Literature DB >> 16839917

Factors affecting the stability of L-glutamine in solution.

K Khan1, M Elia.   

Abstract

The degradation rate of L-glutamine in water, various buffers, and intravenous solutions was assessed over a period of 2 weeks. Measurements were made at various temperatures (22-24 degrees C, and 4 degrees C and -80 degrees C) and pH, and also in the presence and absence of light and oxygen (intravenous solutions only). At 22-24 degrees C, the degradation rate of glutamine was variable depending on the type of solution used (0.23% in water pH 6.5; 0.22% in dextrose/water [15% w/v]; 0.8% in mixed total parenteral nutrition (TPN) solution), and on the pH, molarity and type of buffer used. The degradation rate was essentially unaffected by light and O(2). The degradation rate of L-glutamine in the intravenous solutions was less than 0.15%/day at 4 degrees C, minimal at -20 degrees C (<0.03%/day), and undetectable at -80 degrees C. Glutamine degradation resulted in the equimolar formation of ammonia and no associated formation of glutamate. It is concluded that (a) glutamine degradation in solution is variable due to the effect of physico-chemical factors, and (b) glutamine degradation in TPN solutions is sufficiently slow, especially during storage at 4 degrees C or below, to consider its inclusion in such solutions, for clinical use.

Entities:  

Year:  1991        PMID: 16839917     DOI: 10.1016/0261-5614(91)90037-d

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  8 in total

1.  Stability of Minimum Essential Medium functionality despite L-glutamine decomposition.

Authors:  Maja Jagušić; Dubravko Forčić; Marija Brgles; Leonida Kutle; Maja Šantak; Mladen Jergović; Ljerka Kotarski; Krešo Bendelja; Beata Halassy
Journal:  Cytotechnology       Date:  2015-04-24       Impact factor: 2.058

2.  Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.

Authors:  Nicolai J Wewer Albrechtsen; Kristine Færch; Troels M Jensen; Daniel R Witte; Jens Pedersen; Yuvaraj Mahendran; Anna E Jonsson; Katrine D Galsgaard; Marie Winther-Sørensen; Signe S Torekov; Torsten Lauritzen; Oluf Pedersen; Filip K Knop; Torben Hansen; Marit E Jørgensen; Dorte Vistisen; Jens J Holst
Journal:  Diabetologia       Date:  2018-01-05       Impact factor: 10.122

3.  Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.

Authors:  B Daniele; F Perrone; C Gallo; S Pignata; S De Martino; R De Vivo; E Barletta; R Tambaro; R Abbiati; L D'Agostino
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

4.  Arginyl-glutamine dipeptide or docosahexaenoic acid attenuates hyperoxia-induced small intestinal injury in neonatal mice.

Authors:  Nan Li; Liya Ma; Xueyan Liu; Lynn Shaw; Sergio Li Calzi; Maria B Grant; Josef Neu
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

5.  Strategies to assess and optimize stability of endogenous amines during cerebrospinal fluid sampling.

Authors:  Marek J Noga; Ronald Zielman; Robin M van Dongen; Sabine Bos; Amy Harms; Gisela M Terwindt; Arn M J M van den Maagdenberg; Thomas Hankemeier; Michel D Ferrari
Journal:  Metabolomics       Date:  2018-03-05       Impact factor: 4.290

6.  Viability of Toxoplasma gondii tachyzoites in different conditions for parasite transportation.

Authors:  Thi Thuy Nguyen; Ketsarin Kamyingkird; Waraphon Phimpraphai; Tawin Inpankaew
Journal:  Vet World       Date:  2022-01-29

7.  Glutamine Analogues As Adjunctive Therapy for Infectious Diarrhea.

Authors:  Benedito A. Carneiro-Filho; Oluma Y. Bushen; Gerly A.C. Brito; Aldo A.M. Lima; Richard L. Guerrant
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.663

8.  Interaction of Atmospheric-Pressure Air Microplasmas with Amino Acids as Fundamental Processes in Aqueous Solution.

Authors:  Renwu Zhou; Rusen Zhou; Jinxing Zhuang; Zichao Zong; Xianhui Zhang; Dongping Liu; Kateryna Bazaka; Kostya Ostrikov
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.